Zhang Jun-Jing, Wang Ze-Xin, Niu Jian-Xiang, Zhang Ming, An Ni, Li Peng-Fei, Zheng Wei-Hua
Department of General Surgery, Huhhot First Hospital, Huhhot 010030, Inner Mongolia Autonomous Region, China.
Department of Interventional Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010000, Inner Mongolia Autonomous Region, China.
World J Clin Cases. 2021 Aug 6;9(22):6469-6477. doi: 10.12998/wjcc.v9.i22.6469.
About 20%-30% of newly diagnosed hepatocellular carcinoma (HCC) patients are surgically feasible due to a variety of reasons. Active conversion therapy may provide opportunities of surgery for these patients. Nevertheless, the choice of surgical procedure is controversial after successful conversion therapy. We report a patient with HCC who underwent successful laparoscopic right trisectionectomy after conversion therapy with portal vein embolization and transarterial chemoembolization.
A 67-year-old male patient presented to our hospital with epigastric distention/ discomfort and nausea/vomiting for more than 1 mo. Contrast-enhanced computed tomography scan of the abdomen demonstrated multiple tumors (the largest was ≥ 10 cm in diameter) located in the right liver and left medial lobe, and the left lateral lobe was normal. The future remnant liver (FRL) of the left lateral lobe accounted for only 18% of total liver volume after virtual resection on the three-dimensional liver model. Conversion therapy was adopted after orally administered entecavir for antiviral treatment. First, the right portal vein was embolized. Then tumor embolization was performed the variant hepatic arteries. After 3 wk, the FRL of the left lateral lobe accounted for nearly 30% of the total liver volume. Totally laparoscopic right trisectionectomy was performed under combined epidural and general anesthesia. The resection was performed an anterior approach. The operating time was 240 min. No clamping was required during the surgery, and the intraoperative blood loss was 300 mL. There were no postoperative complications such as bile leakage, and the incision healed well. The patient was discharged on the 8 postoperative day. During the 3-mo follow-up, there was no recurrence and obvious hyperplasia of residual liver was observed. Alpha-fetoprotein decreased significantly and tended to be normal.
Due to the different biological characteristics of the liver cancer and the pathophysiological features of the liver from other organs, the conversion treatment should take into account both the feasibility of tumor downstaging and the volume and function of the remnant liver. Our case provides a reference for clinicians in terms of both conversion therapy and laparoscopic right trisectionectomy.
约20%-30%新诊断的肝细胞癌(HCC)患者因各种原因在手术上可行。积极的转化治疗可能为这些患者提供手术机会。然而,成功的转化治疗后手术方式的选择存在争议。我们报告1例HCC患者,其在门静脉栓塞和经动脉化疗栓塞转化治疗后成功接受了腹腔镜右三叶切除术。
1例67岁男性患者因上腹部胀满/不适及恶心/呕吐1个多月就诊于我院。腹部增强CT扫描显示右肝和左内叶有多个肿瘤(最大直径≥10 cm),左外叶正常。在三维肝脏模型上虚拟切除后,左外叶的未来残余肝(FRL)仅占全肝体积的18%。口服恩替卡韦进行抗病毒治疗后采用转化治疗。首先,栓塞右门静脉。然后对变异肝动脉进行肿瘤栓塞。3周后,左外叶的FRL占全肝体积近30%。在硬膜外麻醉和全身麻醉联合下进行完全腹腔镜右三叶切除术。采用前入路进行切除。手术时间为240分钟。手术过程中无需阻断,术中失血300 mL。术后无胆漏等并发症,切口愈合良好。患者术后第8天出院。在3个月的随访中,无复发,残余肝未见明显增生。甲胎蛋白显著下降并趋于正常。
由于肝癌的生物学特性及肝脏与其他器官不同的病理生理特点,转化治疗应兼顾肿瘤降期的可行性及残余肝的体积和功能。我们的病例在转化治疗和腹腔镜右三叶切除术方面为临床医生提供了参考。